Postpartum exhaustion is real, and the appeal of supplements promising increased energy and faster recovery is understandable. But when you’re nursing, every substance you consume potentially reaches your baby through breast milk. This guide breaks down what we actually know about NAD+ supplementation during lactation, what remains unknown, and how to make informed decisions for you and your infant.
If you need a broad foundation first, our overview of NAD supplements, risks, and product forms gives the wider context behind the safety questions discussed here.
Short answer: can you take NAD+ while breastfeeding?
As of 2026, there is insufficient safety data to recommend NAD+ (nicotinamide adenine dinucleotide) or NAD-boosting supplements like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) during breastfeeding. Major professional guidelines have not specifically endorsed these supplements for nursing mothers, and most clinicians advise caution or avoidance unless you’re enrolled in a supervised clinical trial. Current health guidelines do not recommend NAD+ or its precursors for nursing mothers due to a lack of safety data.
Some preclinical research in animal models (mice and sows, conducted between 2019–2025) suggests potential benefits for lactation and offspring development. However, animal data cannot be assumed safe or directly applicable to human lactation. Different species, controlled laboratory diets, and higher relative doses than typical over-the-counter supplements make direct translation problematic.
It’s crucial to distinguish between standard niacin in prenatal vitamins and high-dose NAD+ supplements. Prescribed, standard-dose vitamin B3 in prenatal or postnatal vitamins is generally considered compatible with breastfeeding under medical supervision. High-dose NR, NMN capsules, or NAD+ infusions represent a different category of intervention that has not been formally studied in breastfeeding mothers or their infants.
Key takeaways:
No large human clinical studies have tested NAD+ supplement safety in breastfeeding women
Animal studies show promise but cannot establish human safety
Standard prenatal niacin differs from pharmacologic NAD+ boosters
Current evidence supports caution or avoidance during lactation
What is NAD+ and how is it related to breastfeeding?
Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in every cell of your body. It’s essential for cellular energy production through ATP synthesis, supports DNA repair, and plays a central role in metabolism. Without adequate NAD+, cells cannot efficiently convert nutrients into usable energy.
NAD+ levels naturally decline with age, which can contribute to fatigue, brain fog, and slowed metabolism. Supplementation is sometimes considered to help counteract these age-related changes by restoring cellular functions.
Pregnancy and the postpartum period are metabolically demanding. Research indicates that postpartum NAD+ homeostasis is depressed, meaning your body’s NAD+ balance shifts significantly after delivery. The mammary gland becomes one of the most metabolically active tissues during peak lactation, requiring substantial energy for milk production.
The biological role of NAD+ in lactation:
Powers the synthesis of lactose, fats, and proteins in breast milk
Supports mitochondrial health in mammary gland tissue
Helps maintain metabolic homeostasis during the energy demands of nursing
NR is naturally present in trace amounts in human breast milk
Research shows median NMN concentration in breast milk is approximately 9.2 μM
NMN concentration in breast milk correlates positively with infant neurodevelopmental outcomes at 24 months
What do animal studies say about NAD+ and lactation?
Most detailed mechanistic data on NAD+ and breastfeeding come from animal models rather than human nursing mothers. These studies help us understand how NAD+ supplementation might affect lactation, but they carry important limitations.
In sow (pig) model research conducted around 2023–2025, investigators supplemented multiparous Landrace × Yorkshire sows with maternal nicotinamide riboside (approximately 25 mg/kg/day) from late pregnancy. The results showed restored mammary NAD+ levels, improved milk nutrient density, and better offspring weight gain and development.
Mouse studies published in Cell Rep (2019) demonstrated that postpartum mice given NR showed:
Increased NAD+ metabolites in mammary glands
Higher milk production and longer nursing time
More efficient postpartum weight loss
Improved motor and cognitive outcomes in adult offspring development
These studies also measured NAD+ shifts in liver and blood, suggesting the postpartum liver may export NAD+ precursors to support the energy-hungry mammary gland.
Critical limitations to consider:
Different species with different milk composition than humans
Higher relative doses than typical supplements
Controlled laboratory conditions not reflecting real-world use
No direct assessment of long-term safety for human infants
Animal data helps us understand mechanisms but cannot replace human lactation safety studies. More studies are needed before these findings can inform clinical recommendations for breastfeeding women.
Is NAD+ supplementation safe while breastfeeding?
As of 2026, there are no large, well-controlled clinical studies specifically testing the safety of high-dose NAD+, NR, or NMN in breastfeeding women and their infants. While NR supplementation and NMN have been studied in adults—often older adults aged 40 and above—these studies typically exclude pregnant and breastfeeding participants.
The ongoing MOONRISE Study at UC Davis aims to determine whether NR supplementation improves milk production in mothers of extremely preterm infants. This trial explicitly acknowledges that NR has yet to be studied as a supplement for increasing milk production in lactating human women. Until results are available, we lack direct safety data on milk transfer, infant exposure, and long-term neurodevelopmental outcomes.
Current evidence gaps and theoretical risks:
Unknown levels of NAD+ metabolites that may transfer to breast milk
Potential effects on rapidly growing infant cells remain fully understood
Possible potential interactions with underlying maternal conditions (liver disease, cardiovascular disease, active cancer)
NAD+ metabolism in cancer cell metabolism raises concerns for mothers with undiagnosed malignancies
Some IV therapy providers list pregnancy and breastfeeding as contraindications
Cancer patients and those on complex medications face additional considerations
Allergic reactions to supplement ingredients cannot be ruled out without testing
Standard nutritional vitamin B3 intake—typical dietary niacin at 14-18 mg daily in prenatal vitamins—is considered compatible with breastfeeding. This is not the same as pharmacologic NAD+ IVs or high-dose capsules (often 250-1000 mg daily). The dosage difference is significant: supplements can be 50-70 times the recommended dietary allowance.
Dietary supplements are widely used by breastfeeding mothers, yet many lack proven safety, efficacy, and consistent quality. Variability in product content and misleading labeling mean that supplement safety cannot be assumed based on marketing claims alone.
Potential benefits vs. unknown risks for nursing mothers
Many women consider NAD-supporting supplements for reasons including chronic fatigue, brain fog, postpartum mood concerns, weight loss goals, or perceived healthy aging benefits. These motivations reflect genuine struggles—postpartum fatigue affects 60-80% of new mothers.
Potential theoretical benefits (extrapolated from non-lactating adult studies):
Better mitochondrial function and cellular energy
Improved energy levels and recovery support
Enhanced exercise capacity
Support for metabolic health markers including insulin sensitivity
These outcomes are not proven in breastfeeding women
Unknown risks and infant concerns:
How much NAD+ or its precursors enter breast milk remains unquantified
What blood levels infants might reach is unknown
Whether chronic exposure during the first 6-12 months could affect growth, organ development, or long-term behavior
Effects on rapidly developing infant brain and body systems
Potential to alter the naturally-evolved milk composition
High-risk scenarios requiring specialist oversight or avoidance:
Mothers with active cancer, especially hormone-sensitive types
Serious liver disease affecting NAD+ metabolism
Cardiovascular disease or complex medication regimens
Known allergy to supplement components
Taking drugs that may interact with NAD+ pathways
Breastfeeding itself already provides substantial long-term benefits for both mother and child—reduced risk of certain infections, obesity, and type 2 diabetes for the child; reduced breast and ovarian cancer risk for the mother. Any supplement use should protect, not jeopardize, breastfeeding success.
Practical guidance if you’re breastfeeding and considering NAD+
Postpartum exhaustion is nearly universal and profoundly distressing. The pressure to “bounce back” creates powerful motivation to seek solutions. But evidence-based guidance should drive your decisions.
Step-by-step approach:
Consult before starting. Discuss any NAD+ product—including NR, NMN, NAD+ IVs, and combination “longevity” stacks—with your healthcare provider, midwife, pediatrician, or lactation-savvy pharmacist.
Consider the conservative default. Avoid high-dose NAD+ infusions and high-strength oral NAD-boosters during exclusive breastfeeding (commonly the first 4-6 months) unless enrolled in a clinical study.
If proceeding despite guidance:
Review all current medications and supplements with a clinician
Start with the lowest effective dose
Avoid stacking multiple energizing agents (stimulants plus NAD+)
Monitor your symptoms and your baby’s sleep, feeding, and growth
First-line strategies for postpartum energy (evidence-based):
Adequate calories and protein (lactation requires ~300 extra calories daily)
Iron and vitamin D assessment and supplementation if deficient
Regular light activity as tolerated
Sleep optimization through support systems
Evaluation and treatment for thyroid disorders or postpartum mood conditions
Marketing claims to question:
“Clinically proven” often refers to non-breastfeeding adult populations
“Bioidentical” or “natural” does not mean safe for infants
Many NAD+ products have not been tested in breastfeeding populations
Efficacy claims may not apply to lactating women
Frequently asked questions about NAD+ and breastfeeding
Is NAD+ the same as the niacin in my prenatal vitamin?
NAD+ and niacin (vitamin B3) are biochemically related but pharmacologically distinct. Prenatal vitamins contain niacin at 14-18 mg daily, which is generally considered safe and well tolerated. High-dose NAD+, NR, or NMN supplements (250-1000 mg daily) are pharmacologic and not fully studied in breastfeeding. Decades of safe use of standard prenatal niacin does not extend to high-dose NAD+ precursors.
Can I take NAD+ if I am partially breastfeeding and supplementing with formula?
Even partial breastfeeding means some infant exposure through milk, so the same caution applies. The risk doesn’t substantially decrease because the milk you produce still receives NAD+ metabolites from maternal circulation. Current evidence suggests treating any breastfeeding as a reason for caution.
What about topical NAD+ creams or serums while breastfeeding?
Topical products present theoretically lower systemic absorption than oral supplements or IV infusions. However, this is not rigorously studied. Avoid application on or near the breasts or areas that the baby might contact. Face serums or hand creams present minimal risk compared to nipple creams or products applied where the infant touches.
If I stopped NAD+ when I got pregnant, when is it safest to restart?
Many clinicians prefer waiting until breastfeeding is fully weaned, or at least until the baby’s first year is complete. The first year represents the period of most rapid infant development and greatest vulnerability. Individual medical advice based on your health history should determine the appropriate timing.
I’m exhausted and struggling postpartum—should I try NAD+?
Feeling tired and depleted postpartum is common and usually better addressed through evaluation for treatable conditions. Anemia, thyroid disorders, vitamin D deficiency, and postpartum depression can all cause fatigue and respond to evidence-based treatment. Seek a full postpartum medical evaluation rather than self-treating with supplements. Your body and your baby deserve answers, not experiments.
Key takeaways and how to decide what’s right for you
The research landscape on NAD+ and breastfeeding points toward caution. While the science of NAD+ metabolism is promising for understanding cellular energy and healthy aging, applying this to nursing mothers and their infants requires data we don’t yet have.
Making decisions centered on infant safety and preservation of breastfeeding—rather than speculative performance benefits—is the most responsible approach. If you’re considering NAD+ because you feel unwell, fatigued, or unable to cope, this signals the need for a comprehensive postpartum evaluation, not supplement self-treatment.
Decision-making checkpoints:
Limited human data exists on NAD+ use during lactation—essentially no clinical trials
Animal models show promising but preliminary findings that cannot establish human safety
Unknown long-term infant effects from chronic exposure to elevated maternal NAD+ metabolites
Standard prenatal niacin differs fundamentally from high-dose NAD+ supplements
Keep a list of all supplements and medications to share with every healthcare provider
Prioritize evidence-based strategies: nutrition, sleep, iron/vitamin D status, mood support
There’s no single “right” way to handle postpartum recovery. Every mother’s circumstances, health history, and values vary depending on individual factors. But making decisions with transparent risk-benefit information and professional guidance is the safest path for both you and your baby.
